A review of the complaint log shows that there are no other complaints associated with the parent lot number (m19d1150).Manufacturing review of the device history record for the reported lot shows that all units were quality released on 4/11/19 having met all internal qc acceptance requirements.All sterilization records, and bioburden testing indicate successful sterilization process, and passing lal and product sterility results allowed the lot to be released having met all criteria for manufacturing release.There were no non-conformances associated with the manufacturing lot during production, sterilization and final packaging.The site noted that the event is probably related to the procedure and possibly related to the device.It was also noted that the physician believes the event could be related to the inflammatory response.The exact relationship to the device cannot be conclusively determined.The instructions for use for the cangaroo envelope (art-20662b) under the section, potential complications, states in part, the following device-related complications are possible: allergic reaction to ecm, inflammation, seroma.
|